These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24009543)

  • 21. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
    Song H; Wang Z; Zheng D; Fang W; Li Y; Liu Y; Niu Z; Qiu B
    Biotechnol Lett; 2005 Nov; 27(21):1669-74. PubMed ID: 16247672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
    Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
    Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
    Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immune responses against foot-and-mouth disease virus by vaccination with a DNA vaccine expressing virus-like particles.
    Jin H; Xiao W; Xiao C; Yu Y; Kang Y; Du X; Wei X; Wang B
    Viral Immunol; 2007 Sep; 20(3):429-40. PubMed ID: 17931113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route.
    Qi X; Lu Q; Hu J; Xiong S
    Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME; El-Deeb AH; Zeidan SM; Hussein HA; Abu-El-Naga HI
    Vet Microbiol; 2017 Oct; 210():1-7. PubMed ID: 29103677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.
    Yang NS; Wang JH; Lin KF; Wang CY; Kim SA; Yang YL; Jong MH; Kuo TY; Lai SS; Cheng RH; Chan MT; Liang SM
    J Gene Med; 2005 Jun; 7(6):708-17. PubMed ID: 15693054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C5aR
    Kim SH; Shim EH; Kim DJ; Jang YS
    NPJ Vaccines; 2023 Aug; 8(1):120. PubMed ID: 37580335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
    Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S
    Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
    Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
    PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
    Jones DI; Pollara JJ; Johnson-Weaver BT; LaBranche CC; Montefiori DC; Pickup DJ; Permar SR; Abraham SN; Maddaloni M; Pascual DW; Staats HF
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice.
    Kimoto T; Kim H; Sakai S; Takahashi E; Kido H
    Vaccine; 2019 Jan; 37(4):612-622. PubMed ID: 30553569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foot-and-Mouth Disease Virus Structural Protein VP1 Destroys the Stability of TPL2 Trimer by Degradation TPL2 to Evade Host Antiviral Immunity.
    Zhang K; Yan M; Hao J; Shen C; Zhu Z; Zhang D; Hou J; Xu G; Li D; Zheng H; Liu X
    J Virol; 2021 Apr; 95(7):. PubMed ID: 33361430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.
    Yang CD; Liao JT; Lai CY; Jong MH; Liang CM; Lin YL; Lin NS; Hsu YH; Liang SM
    BMC Biotechnol; 2007 Sep; 7():62. PubMed ID: 17900346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.